MacroGenics
MGNX
#9452
Rank
C$0.17 B
Marketcap
C$2.81
Share price
-1.01%
Change (1 day)
40.50%
Change (1 year)

MacroGenics (MGNX) - Total assets

Total assets on the balance sheet as of June 2026 : C$0.49 Billion

According to MacroGenics's latest financial reports the company's total assets are C$0.49 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

MacroGenics - Total assets on balance sheet (from 2012 to 2026)

Total assets by year

Year Total assets Change
2025-12-31C$0.35 B-6.32%
2024-12-31C$0.37 B-5.14%
2023-12-31C$0.39 B4%
2022-12-31C$0.38 B-10.92%
2021-12-31C$0.42 B-11.53%
2020-12-31C$0.48 B18.32%
2019-12-31C$0.40 B-9.79%
2018-12-31C$0.45 B-3.75%
2017-12-31C$0.47 B12.38%
2016-12-31C$0.41 B-16.07%
2015-12-31C$0.49 B146.98%
2014-12-31C$0.20 B50.71%
2013-12-31C$0.13 B150.52%
2012-12-31C$53.44 M-16.17%
2011-12-31C$63.75 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
C$288.49 B 58,129.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$212.38 B 42,768.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$137.17 B 27,588.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$70.80 B 14,190.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$186.18 B 37,479.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$127.33 B 25,600.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
C$1.03 B 109.88%๐Ÿ‡บ๐Ÿ‡ธ USA